Skip to content

Spine FA3 - a Prospective, International, Multicenter Cohort Study on Treatment of of AO A3 Thoracolumbar Fractures

Comparison of Surgical Versus Conservative Treatment of AO Type A3 Thoracolumbar Fractures Without Neurological Deficits Prospective, International, Multicenter Cohort Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01751633
Acronym
FA3
Enrollment
38
Registered
2012-12-18
Start date
2013-01-31
Completion date
2015-12-31
Last updated
2020-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Single Level Stable Thoracolumbar Fracture Type AO A3, Multiple Level Stable Thoracolumbar Fracture Type AO A3

Keywords

Burst fractures, Thoracic or Lumbar Vertebrae/injuries [MeSH], Thoracic or Lumbar Vertebrae/surgery [MeSH], Spinal Fusion/methods [MeSH], Thoracolumbar fracture management, Quality of life, Functional outcome

Brief summary

Thoracolumbar fractures are the most common spinal fractures with an average annual incidence between 18 and 30 per 100'000 inhabitants. The majority of these fractures are AO type A3 (burst fractures). Although patients with burst fractures report a reduced quality of life and chronic pain, there is no clear evidence whether surgical or conservative treatment offer better functional and back-pain related outcomes. The indications for the selection of an ideal treatment for these fractures without neurological deficits remain controversial. The purpose of this study is to evaluate whether patients with thoracolumbar fractures without neurological deficit being surgically treated show faster recovery and better improvement of function than patients being conservatively treated.

Interventions

PROCEDURESurgical
PROCEDUREConservative treatment

Sponsors

AO Clinical Investigation and Publishing Documentation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-65 years * Diagnosis of single or multiple stable thoracolumbar fracture(s) * Level T10- L3 * Type AO A3 or A4 * Radiologically confirmed by Rx or CT * Fracture induced kyphotic deformity lower or equal to 20-35 degrees * Definitive treatment (surgical or conservative) within 10 days after injury * American Spinal Injury Association (ASIA) Impairment Scale = E (normal ) * Ability to understand patient information / informed consent form * Willingness and ability to participate in the clinical investigation including imaging and follow-up procedures (FUs) * Signed informed consent

Exclusion criteria

* Open fracture * Polytrauma * Pathologic fracture * Disruption of the posterior ligamentous complex between T10 and L3 * Clinically evident osteoporosis as assessed by the investigator * Spinal luxation * Associated severe lesions as assessed by the investigator * Spinal lesion due to gun or projectile * Pre-existing spinal column deformity * Prior spinal surgeries * BMI \> 40 kg/m2 * Any severe medically not managed systemic disease * Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reli-able assessment * Pregnancy or women planning to conceive within the study period * Prisoner * Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Design outcomes

Primary

MeasureTime frameDescription
Roland-Morris Disability Questionnaire (RMDQ)6 week follow upImprovement in functional outcome from baseline to 6 week follow up (FU) measured with the Roland-Morris Disability Questionnaire (RMDQ)

Secondary

MeasureTime frame
Pain (Numeric Rating Scale (NRS))Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months FU
Radiologic progress taking into account RX, CT and optionally MRIbaseline and at follow up after 6 weeks, 3, 6, 12 and 24 months
Quality of return to work (Denis Work Scale)Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Back pain related disability (Roland-Morris Disability Questionnaire RMDQ)Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Conservative treatment failure rate (eg, change to surgical treatment)Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Rates of local adverse events (AE)Assessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up
Time to return to workAssessed at baseline, 6 weeks, 3, 6, 12 and 24 months follow up

Countries

Brazil, Chile, Czechia, Germany, Italy, Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026